viewTharisa PLC

Tharisa PLC - Trading statement - results for FY2019

RNS Number : 2495U
Tharisa PLC
22 November 2019

Tharisa plc

(Incorporated in the Republic of Cyprus with limited liability)

(Registration number HE223412)

JSE share code: THA

LSE share code: THS

A2X share code: THA

ISIN: CY0103562118


('Tharisa' or the 'Company')

Trading statement - results for the year ended 30 September 2019

In terms of section 3.4(b) of the JSE Listings Requirements, companies are required to provide guidance to the market when they are satisfied that a reasonable degree of certainty exists that the financial results for the current reporting period will differ by at least 20% from the results of the previous corresponding reporting period.

A production update for the financial year ended 30 September 2019 was released on the JSE Stock Exchange News Service and LSE Regulatory News Service on 9 October 2019.  Operational improvements were recorded in the second half of the year although the Company did not attain its production guidance for the year, reporting 139.7 koz of contained PGMs and 1.29 Mt of chrome concentrates.

Tharisa is preparing its financial statements for FY 2019, with the financial results expected to be released on or around 28 November 2019.  The contributing factors to this trading statement, which have been previously noted within the production update, are as follows:

·    a weakening of the metallurgical grade chrome concentrate price with the received price compared to the previous financial year being down by 12.9% to US$162/t;

·    a pit redesign undertaken throughout the year impacting overall volumes; and

·    overall PGM production down 8.3% and a reduction of 11.0% in chrome concentrate production.

Tharisa's basic earnings per share ('EPS') and headline earnings per share ('HEPS') for the twelve months ended 30 September 2019 are expected to be US$ 4 cents per share, with a tolerance of 10%.  This is a decrease of 79% relative to the EPS and HEPS of US$ 19 cents per share for the financial year ended 30 September 2018. 

The financial information on which this trading statement is based has not been reviewed and reported on by the Company's auditors.



Paphos, Cyprus

22 November 2019

JSE Sponsor

Investec Bank Limited

Investor relations contacts:

Ilja Graulich (Head of Investor Relations and Communications)

+27 11 996 3500

+27 83 604 0820

[email protected]

Daniel Thöle (Investor Relations and Communications)

+27 11 996 3500


Financial PR contacts:

Bobby Morse / Augustine Chipungu

+44 020 7466 5000

[email protected] 

Broker contacts:

Peel Hunt LLP (UK Joint Broker)

Ross Allister / James Bavister / David McKeown

+44 207 7418 8900

BMO Capital Markets Limited (UK Joint Broker)

Jeffrey Couch / Thomas Rider

+44 020 7236 1010

Berenberg (UK Joint Broker)

Matthew Armitt / Detlir Elezi

+44 20 3207 7800

Nedbank Limited (acting through its Corporate and Investment Banking division) (RSA Broker)

Shabbir Norath

+27 11 295 6575


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Quick facts: Tharisa PLC

Price: 76.5

Market: LSE
Market Cap: £203.96 m

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Tharisa CEO reports on 'knock-out' quarter for productivity

Tharisa PLC's (LON:THS) Phoevos Pouroulis tells Proactive London's Andrew Scott they delivered what he describes as a knock-out quarter in terms of productivity with both May and June achieving consecutive record ROM output levels. ''In a very challenging environment with the pandemic taking...

on 9/7/20